Teleflex Incorporated
Teleflex Incorporated
TFX
Valuace
85
Růst
30
Zdraví
85
Cena
$ 107.94
Dnes
--1.61 (-1.54%)
Souhrn
Výkazy
Ukazatele
Profil
Držitelé
Návštěvnost webu
Konkurence
Zprávy společnosti
Kapitalizace
4.8B
Obrat
3B
Zisk
-1B
Aktiva
8B
Dluh
3B
ROE
-9%
ROA
-4%
PE
-5
PS
2
Cena 1R
103-186
⌀ Cena
122.20
Dividenda
0.0(0.0%)
Čtvrtletní 10-Q
10-Q
Celoroční 10-K
8-K
Nadcházející oznámení zisků
29-04-2026
Poslední dividenda
14-11-2025

Profil

Společnost Teleflex Incorporated vyvíjí, vyvíjí, vyrábí a dodává zdravotnické prostředky na jedno použití pro běžné diagnostické a terapeutické postupy v kritické péči a chirurgických aplikacích po celém světě. Poskytuje cévní přístupové produkty, které zahrnují cévky značky Arrow, navigační a polohovací systémy cév a systémy pro nitrooční přístup pro podávání nitrožilních terapií, měření krevního tlaku a odebírání krevních vzorků prostřednictvím jediného místa vpichu. Společnost také nabízí intervenční produkty, které se skládají z různých koronárních katetrů, strukturální terapie srdce a periferní intervence a srdeční asistence, které jsou používány intervenčními kardiology a radiology, a vaskulárními chirurgy; a značkové katetry Arrow, Guideline a Trapliner katetry, Manta Caskulární uzávěr a Arrow Oncontrol zařízení. Poskytuje přípravky pro anestezii, jako jsou přípravky pro zvládání dýchacích cest a bolesti, pro podporu nemocniční, urgentní medicíny a vojenských kanálů, a chirurgické přípravky, včetně kovových a polymerních ligačních klipů a chirurgických systémů pro uzavření fascií, které se používají při laparoskopických chirurgických zákrocích, perkutánních chirurgických systémech a dalších chirurgických nástrojích. Společnost také nabízí intervenční urologické přípravky zahrnující systém UroLift, invazivní technologii pro léčbu příznaků dolních močových cest způsobených benigní hyperplazií prostaty a respirační přípravky, včetně kyslíkové a aerosolové terapie, spirometrie a ventilačních přípravků pro použití v různých zařízeních péče. Poskytuje urologické produkty, jako jsou katétry, sběrače moči a příslušenství pro katetrizaci a produkty pro operativní endourologii; a služby řízení močového měchýře. Společnost slouží nemocnicím a poskytovatelům zdravotní péče, výrobcům zdravotnických prostředků a domácím pečovatelským trhům. Společnost byla založena v roce 1943 a sídlí v Wayne v Pensylvánii.
Sektor
Healthcare
Odvětví
Medical - Instruments & Supplies
Počet zaměstnanců
14100
Založení
1980-03-17
Adresa
550 East Swedesford Road
CEO
Liam J. Kelly

Zahraniční články

Výsledovka

Rozvaha

Peněžní toky

Výsledovka

Výsledovka
Rozvaha
Peněžní toky
V miliónech (USD)
Revenue TTM 2025202420232022202120202019201820172016201520142013201220112010
Total Revenues2,963.61,992.73,047.32,974.52,791.02,809.62,537.22,595.42,448.42,146.31,868.01,809.71,839.81,696.31,551.01,528.91,801.7
Cost of Revenues1,383.9872.01,344.61,327.61,260.01,260.01,212.31,103.81,063.9974.5871.8865.3897.4857.3802.8810.11,007.6
Gross Profit1,579.61,120.81,702.71,646.91,531.11,549.61,324.91,491.61,384.41,171.8996.2944.4942.4838.9748.2718.8794.1
Revenue 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Total Revenues569.0913.0780.9700.7795.4764.4749.7737.8773.9746.4
Cost of Revenues261.5461.4349.8311.2355.5334.2333.2321.7342.5330.1
Gross Profit307.4451.6431.1389.4439.9430.2416.5416.1431.4416.3
Operating Income TTM 2025202420232022202120202019201820172016201520142013201220112010
R&D Expenses0.00.00.0154.4153.8130.8119.7113.9106.284.858.652.161.065.056.348.742.6
Selling General & Admin Expenses0.00.00.0929.9863.7860.1743.6934.4878.7700.0563.3569.0578.7502.2454.5429.3475.3
Depreciation & Amortization211.0177.7274.6242.1245.3169.3266.9231.9210.0155.3117.9108.4111.193.080.585.692.2
Total Operating Expenses1,292.1865.01,551.71,140.71,017.6990.9863.31,048.2984.9784.7621.9621.1639.7567.2510.8478.6517.6
Operating Income287.5255.8151.0506.3499.7628.1423.1427.3321.7372.3319.5315.9284.9233.3-97.4233.2273.6
Operating Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
R&D Expenses0.00.00.00.00.00.00.00.035.937.6
Selling General & Admin Expenses0.00.00.00.00.00.00.00.0260.7213.2
Depreciation & Amortization0.077.965.767.371.868.668.166.064.257.6
Total Operating Expenses271.1481.3275.8263.9550.3280.9299.6420.9296.5250.8
Operating Income36.3-29.7155.3125.6-110.4149.3116.9-4.882.5137.7
Net Income TTM 2025202420232022202120202019201820172016201520142013201220112010
Interest Income7.66.48.012.80.91.31.21.70.90.80.50.50.70.61.61.30.9
Interest Expense106.0100.283.585.154.357.066.580.3103.082.554.961.365.556.969.670.380.0
Other Expense-494.3-231.3-75.5-72.3-53.8-68.6-65.3-87.4-77.8-20.4-74.1-17.9-17.9-39.7-334.8-22.5-49.5
IBT-206.824.675.5434.0445.9559.5357.7339.9219.6284.9245.7244.6220.1175.7-165.4148.7147.8
Income Tax Expense-12.1-34.05.376.483.074.321.9-122.123.2129.68.17.828.723.516.427.021.9
Net Income-905.6-905.669.7356.3363.1485.4335.3461.5200.8152.5237.4244.9187.7150.9-190.1323.3201.1
Net Income TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Interest Income1.92.21.61.92.32.31.81.73.37.5
Interest Expense28.237.621.718.518.621.121.222.725.823.2
Other Expense-48.8-408.9-20.1-16.6-16.4-18.8-19.4-21.0-22.5-15.7
IBT-12.4-438.6135.2108.9-126.8130.697.5-25.860.0149.6
Income Tax Expense-8.9-29.712.713.89.919.617.3-41.628.811.9
Net Income-714.3-408.9122.695.0-136.7111.080.015.331.1137.1
Per Share Data TTM 2025202420232022202120202019201820172016201520142013201220112010
EPS$0.00$0.00$0.00$7.58$7.74$10.38$7.21$9.99$4.39$3.39$5.48$5.89$4.54$3.67$-4.65$7.98$5.04
EPS Diluted$0.00$0.00$0.00$7.53$7.68$10.23$7.09$9.80$4.29$3.27$4.98$5.10$4.04$3.45$-4.65$7.92$4.99
Shares Outstanding44.244.646.847.046.946.846.546.245.745.043.341.641.441.140.940.539.9
Diluted Shares Outstanding44.244.747.147.347.347.447.347.146.846.747.648.146.543.740.940.840.3
Per Share Data TTM 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
EPS$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.66$2.92
EPS Diluted$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.66$2.90
Shares Outstanding44.244.245.845.846.346.747.247.147.047.0
Diluted Shares Outstanding44.244.245.945.946.447.047.447.447.347.3
Current Assets TTM 202420232022202120202019201820172016201520142013201220112010
Cash And Equivalents238.6290.2222.8292.0445.1375.9301.1357.2333.6543.8338.4303.2432.0337.0584.1208.5
Short Term Investments16.416.00.00.00.00.00.00.00.00.00.00.00.00.00.00.0
Total Cash & ST Investments238.6306.2222.8292.0445.1375.9301.1357.2333.6543.8338.4303.2432.0337.0584.1208.5
Accounts Receivable448.9459.5443.5408.8383.6395.1418.7366.3345.9272.0262.4273.7295.3298.0286.2298.1
Inventory636.9600.1626.2578.5477.6513.2476.6427.8395.7316.2330.3335.6333.6323.3298.8338.6
Other Current Assets113.7105.3114.9125.1117.3115.497.972.547.940.437.535.739.828.7111.27.6
Total Current Assets1,438.11,471.11,407.41,411.01,429.11,422.41,306.31,236.21,128.81,183.41,006.41,053.21,200.61,069.11,280.3921.2
Current Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Cash And Equivalents354.0253.7284.1290.2243.2238.6237.4222.8881.5250.8
Short Term Investments0.00.00.00.00.00.00.016.967.541.9
Total Cash & ST Investments354.0253.7284.1290.2243.2238.6237.4222.8881.5250.8
Accounts Receivable592.7513.8464.5459.5470.3448.9448.5443.5425.2429.3
Inventory802.5693.7644.0600.1639.9636.9627.9626.2625.1631.6
Other Current Assets236.9262.7146.3121.3145.9113.7119.8114.9165.5134.1
Total Current Assets1,986.01,723.91,538.91,471.11,499.31,438.11,433.61,407.42,097.31,445.8
Long-Term Assets TTM 202420232022202120202019201820172016201520142013201220112010
Net Property, Plant & Equipment604.0611.8603.4578.4573.4574.5543.9432.8383.0302.9316.1317.4325.9297.9251.9287.7
Goodwill2,892.62,632.32,914.12,536.72,504.22,586.02,245.32,246.62,235.61,276.71,295.91,323.61,354.21,249.51,438.51,442.4
Intangible Assets2,379.92,268.72,502.02,306.22,289.12,519.72,156.32,325.12,383.71,091.71,200.01,216.71,255.61,058.8879.8918.5
Long-Term Investments1.20.00.00.00.00.00.00.00.00.00.21.21.72.12.04.9
Other Long-Term Assets119.4102.698.989.469.141.852.435.046.534.857.664.070.161.971.368.0
Total Long-Term Assets6,003.65,626.86,125.15,517.15,442.65,730.15,003.55,041.85,052.72,707.82,872.12,924.03,008.52,670.42,643.82,721.9
Total Assets7,441.67,097.97,532.56,928.16,871.77,152.66,309.86,278.06,181.53,891.23,878.53,977.34,209.03,739.53,924.13,643.2
Long-Term Assets 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Net Property, Plant & Equipment807.6648.1627.3611.8625.1604.0598.1603.4588.1587.8
Goodwill2,537.82,694.12,651.92,632.32,918.62,892.62,898.32,914.12,528.32,546.1
Intangible Assets2,410.42,184.32,226.12,268.72,325.12,379.92,429.52,502.02,180.52,227.9
Long-Term Investments13.615.50.00.00.00.00.00.00.00.0
Other Long-Term Assets103.196.5107.3102.6111.4120.6111.898.993.381.7
Total Long-Term Assets5,886.05,651.45,624.45,626.85,987.06,003.66,044.36,125.15,396.45,449.9
Total Assets7,871.97,375.27,163.37,097.97,486.37,441.67,477.97,532.57,493.66,895.7
Current Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Accounts Payable113.5141.0132.2126.8118.2102.5102.9106.792.069.466.364.172.075.267.184.8
Short-Term Debt93.8100.087.587.5110.0100.550.086.686.6183.1419.9368.4356.34.75.0103.7
Other Current Liabilities329.8367.0345.5367.255.653.9181.5383.283.39.016.321.626.429.00.615.6
Current Liabilities556.8649.4606.7581.5680.1540.0563.1582.5483.9427.6666.7634.9635.1274.4271.0420.8
Current Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Accounts Payable165.9157.6143.0141.0119.3113.5115.9132.2130.7142.1
Short-Term Debt100.0100.0100.0100.096.993.890.687.587.587.5
Other Current Liabilities507.1436.1383.1367.0383.9329.8315.5345.5342.9305.7
Current Liabilities773.0716.1675.9649.4618.8556.8571.0606.7585.4555.4
Long-Term Liabilities TTM 202420232022202120202019201820172016201520142013201220112010
Long-Term Debt1,624.21,655.01,838.91,744.51,856.12,464.01,960.32,072.22,162.9850.3646.0700.0930.0965.3954.8813.4
Capital Leases102.699.2111.3120.4116.086.1101.40.00.00.00.00.00.00.00.00.0
Def. Tax Liability453.0391.1456.1388.9370.1484.7439.6608.2603.7271.4316.0451.5514.7419.3420.8370.8
Total Liabilities2,882.92,819.83,091.62,906.13,117.03,816.13,330.53,738.03,751.01,751.91,867.42,063.62,293.01,958.01,941.31,855.9
Long-Term Liabilities 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Long-Term Debt2,669.21,895.21,905.01,655.01,764.51,726.81,772.31,838.92,173.71,695.1
Capital Leases0.093.597.799.2102.9102.6104.4111.3111.8112.2
Def. Tax Liability423.7374.0385.7391.1445.8453.0456.4456.1389.1385.1
Total Liabilities4,050.13,132.43,068.12,819.83,004.62,882.92,974.73,091.63,179.62,680.6
Total Common Equity TTM 202420232022202120202019201820172016201520142013201220112010
Common Stock48.148.148.048.047.947.847.547.246.945.843.543.443.243.142.942.2
Retained Earnings4,173.04,115.94,109.73,817.33,518.03,096.22,824.92,427.62,285.92,194.62,016.21,827.81,696.41,601.51,847.11,578.9
Comprehensive Income-279.2-316.7-314.4-403.5-347.0-297.3-344.4-341.1-265.1-438.7-371.1-260.9-110.9-132.0-159.4-51.9
Total Common Equity4,558.74,278.14,441.04,022.03,754.73,336.52,979.32,540.02,430.52,139.32,009.31,911.31,913.51,779.01,980.61,783.4
Total Common Equity 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Common Stock48.248.248.248.148.148.148.148.048.048.0
Retained Earnings3,879.24,303.14,195.64,115.94,268.34,173.04,109.04,109.74,094.63,973.4
Comprehensive Income-263.7-258.7-293.1-316.7-258.2-279.2-261.1-314.4-412.2-381.9
Total Common Equity3,821.94,242.94,095.24,278.14,481.74,558.74,503.24,441.04,314.04,215.1
Other TTM 202420232022202120202019201820172016201520142013201220112010
Total Debt1,820.51,755.01,926.41,832.01,966.12,564.52,010.32,158.82,249.61,033.31,065.91,068.41,286.3970.0959.8917.1
Book Value4,558.74,278.14,441.04,022.03,754.73,336.52,979.32,540.02,430.52,139.32,011.11,913.71,916.01,781.51,982.81,787.3
Other 3-20252-20251-20254-20243-20242-20241-20244-20233-20232-2023
Total Debt0.00.00.00.00.00.00.00.00.00.0
Book Value3,821.94,242.94,095.24,278.14,481.74,558.74,503.24,441.04,314.04,215.1
Cash Flow From Operating Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Income264.258.569.7356.3363.1485.4335.3461.5200.8152.5237.8245.7188.8151.7-189.1121.7125.9
Depreciation & Amortization256.0177.7274.6242.1230.6237.4227.3214.1210.0155.3117.9108.4111.193.080.585.692.2
Stock-Based Compensation33.20.031.331.527.222.920.726.922.419.416.914.512.211.98.64.09.6
Change Working Capital-93.4-81.1-1.8-111.8-240.0127.322.3-114.5-44.3132.018.6-3.4-9.9-23.9-17.0-113.1-52.5
Change In Accounts Receivable-10.4-85.5-28.0-15.8-38.5-0.644.7-59.8-23.4-11.0-11.00.49.4-1.3-2.9-43.1-56.3
Change In Accounts Payable-11.6-8.39.7-31.3-24.894.0-3.75.052.139.015.4-0.19.8-0.7-1.5-0.2-1.3
Change In Inventories-19.284.01.7-41.1-110.7-11.1-5.5-53.2-37.2-22.46.4-8.4-15.5-8.9-2.0-32.7-3.7
Other Non-cash Items478.5286.5261.95.5-25.8-111.4-136.520.154.62.546.6-9.9-1.52.8342.39.436.5
Cash from Operations542.80.00.0510.6342.1651.4436.4439.5437.4419.9408.5300.8286.6226.5186.194.5213.1
Cash Flow From Operating Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Income-3.6-408.9122.695.0-136.7111.080.015.331.1137.1
Depreciation & Amortization0.079.465.767.372.668.668.166.064.257.6
Stock-Based Compensation0.08.06.97.87.68.08.67.19.38.1
Change Working Capital164.1-14.4-140.9-68.813.548.4-64.4-57.611.417.1
Change In Accounts Receivable8.0-51.9-36.6-5.1-2.7-14.1-1.7-9.52.6-1.7
Change In Accounts Payable0.00.0-3.4-27.90.032.516.5-50.6-14.637.1
Change In Inventories78.356.3-21.1-29.513.625.5-12.1-11.79.6-5.1
Other Non-cash Items53.6443.5-44.3-28.6245.4-7.43.6138.437.9-20.0
Cash from Operations0.00.00.00.00.00.00.00.0138.9201.6
Cash Flow From Investing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Capital Expenditure-125.3-95.2-126.4-91.4-79.2-71.6-90.7-102.7-80.8-70.9-53.1-61.4-67.6-63.6-65.4-45.1-33.5
Acquisitions-588.9-825.1-0.1-588.9-186.0220.3-766.410.9-117.1-1,762.0-3.8-93.4-40.6-309.1-320.5345.5181.5
Investments-18.6-5.0-7.3-11.3-22.3-18.40.00.00.00.00.00.00.00.00.0-0.20.0
Sales of Investment28.30.07.37.37.37.30.00.00.00.00.00.00.00.00.00.00.0
Other Investing Activities71.60.00.063.122.219.219.318.31.50.00.00.00.00.0-2.4-2.4-0.1
Cash from Investing-647.00.00.0-621.2-257.9156.7-837.8-73.5-196.4-1,832.9-57.0-154.8-108.1-372.6-388.2297.8147.8
Cash Flow From Investing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Capital Expenditure-0.7-29.9-34.6-30.0-32.0-21.2-34.8-38.4-27.7-24.4
Acquisitions1.3-826.5-6.6-0.10.0-0.10.0-0.1-588.7-0.1
Investments0.00.00.0-5.00.00.0-7.30.00.0-11.3
Sales of Investment0.00.07.60.00.00.011.913.70.07.3
Other Investing Activities0.00.00.00.00.00.00.00.052.90.5
Cash from Investing0.00.00.00.00.00.00.00.0-563.5-28.5
Cash Flow From Financing Activities TTM 2025202420232022202120202019201820172016201520142013201220112010
Debt Repaid-800.30.00.0101.3-884.5-1,034.5-938.8-528.5-128.5-1,239.6-714.6-303.8-480.1-375.00.0-455.8-687.2
Debt Issued950.41,755.0-171.3195.7750.3436.21,493.0380.037.82,455.8681.9301.3262.2691.310.2498.51,604.3
Issuance of Common Stock-2.50.00.00.00.011.10.00.00.00.00.00.00.00.00.034.010.7
Repurchase of Common Stock2.4-300.0-200.00.00.0412.50.00.00.00.00.00.00.00.00.0496.5549.4
Dividends Paid-64.00.00.0-63.9-63.8-63.6-63.2-62.8-62.2-61.2-59.0-56.5-56.3-55.9-55.6-55.1-54.3
Other Financing Activities3.00.00.01.2730.8-41.21,457.2172.5-15.82,442.1654.8274.7248.7663.58.3-24.7-155.2
Cash from Financing96.50.00.038.5-217.5-715.8455.2-418.8-206.41,141.3-118.7-85.6-287.7232.6-47.3-5.2-336.6
Cash Flow From Financing Activities 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Debt Repaid0.00.00.00.00.00.00.00.0-223.1478.9
Debt Issued2,769.2774.0-9.8250.0-106.340.8-42.4-63.50.1957.9
Issuance of Common Stock0.00.00.00.00.00.00.00.0-2.50.0
Repurchase of Common Stock0.00.0-1.9-300.0-0.2-200.00.00.02.50.0
Dividends Paid0.00.00.00.00.00.00.00.0-16.0-16.0
Other Financing Activities0.00.00.00.00.00.00.00.01.6-0.9
Cash from Financing0.00.00.00.00.00.00.00.0-237.5462.0
Cash position TTM 2025202420232022202120202019201820172016201520142013201220112010
Net Change in Cash-12.273.7104.8-69.2-153.169.274.8-56.123.6-210.2205.435.1-128.794.9-247.0375.620.1
Closing Cash Balance238.6378.6327.7222.8292.0445.1375.9301.1357.2333.6543.8338.4303.2432.0337.0584.1208.5
Cash position 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Net Change in Cash9.997.4-33.6-10.249.939.21.114.6-658.7630.7
Closing Cash Balance378.6381.3283.9317.5327.7277.8238.6237.4222.8881.5
Free Cash Flow TTM 2025202420232022202120202019201820172016201520142013201220112010
Free Cash Flow417.5245.4509.3419.2263.0579.8345.7336.8356.6349.0355.3239.4219.0163.0120.749.4179.6
Real Free Cash Flow384.3245.4478.0387.7235.7556.9325.0309.9334.1329.6338.5224.9206.8151.1112.045.4169.9
Free Cash Flow 4-20253-20252-20251-20254-20243-20242-20241-20244-20233-2023
Free Cash Flow151.677.7-26.943.1170.4209.856.572.5111.2177.2
Real Free Cash Flow151.669.7-33.835.3162.8201.847.965.4101.9169.1
Nacenění
Finance
Efektivita
Marže
Dividenda
Ostatní

Nacenění

Ukazatel Aktuální Historické Konkurence
P/E-5.133.31703.4
P/S1.63.967.9
P/B1.23.225.8
P/FCF20.935.3396.3
Market cap$4.8$8.3
P/E (Price to Earnings Ratio) – Poměr ceny akcie k zisku za posledních 12 měsíců. Říká, kolik korun investor zaplatí za 1 korunu zisku. Např.: P/E = 15 znamená, že pokud akcie stojí 15 Kč, firma vydělala 1 Kč za poslední rok.

Finance

Ukazatel Aktuální Historické Srovnání
Debt to Assets35.2 %29.6 %0 %
Debt to Income-305.8 %579.9 %0 %
Debt to Free cash flow1243.8 %16.2 %0 %
Interest expense percentage36.9 %15.3 %38.7 %
Current ratio2.6 2.8 0

Efektivita

Ukazatel Aktuální Historické Srovnání
ROE-23.7 %8.4 %0 %
ROA-11.5 %4.2 %0 %
CapEx to Revenue4 %3.2 %10.6 %
RaD to Revenue0 %3.9 %0 %
ROEM210,181.8 106721.9

Marže

Ukazatel Aktuální Historické Srovnání
Gross margin53.7 %52.3 %79.8 %
Operating margin4.4 %14.5 %29.6 %
Net margin-10.3 %10.3 %27.3 %

Dividenda

Ukazatel Aktuální Historické Srovnání
Dividend yield0 %0.9 %0 %
Dividend payout percentage0 %17.4 %0 %
Dividend yield (Dividendový výnos) ukazuje aktuální procentuální výnos z dividend vůči ceně akcie.

Ostatní

Ukazatel Aktuální Historické
Shares outstanding44.2 mil 45.7 mil
Employee count14.1 tis 14.1 tis

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Placený obsah

Pro přístup na tuto stránku budete potřebovat placené členství.

Vyzkoušejte placený obsah na akciích: Apple Inc. nebo CEZ, a. s.

Akciový screener
Kalendář zisků
Super investoři
Porovnání akcií
preloader